182 related articles for article (PubMed ID: 7910097)
21. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
23. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
Lipponen PK; Eskelinen MJ
Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
[TBL] [Abstract][Full Text] [Related]
24. [Monoclonal antibodies (MIB 1, PC 10, 486p and p53) as prognostic factors for recurrent urothelial carcinoma of the urinary bladder].
Hake R; Vorreuther R; Borchmann P; Lukowsky S; Thiele J; Fischer R
Verh Dtsch Ges Pathol; 1993; 77():236-40. PubMed ID: 7511288
[TBL] [Abstract][Full Text] [Related]
25. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
Helpap B; Loesevitz L; Bulatko A
Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma of the bladder.
Celikel C; Dillioğlugil O; Türkeri LN; Başaran M; Yalçiner A; Küllü S; Akdaş A
Eur Urol; 1995; 28(2):152-7. PubMed ID: 8529742
[TBL] [Abstract][Full Text] [Related]
27. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.
Pich A; Chiusa L; Pisani P; Krengli M; Pia F; Navone R
J Cancer Res Clin Oncol; 1992; 119(2):106-10. PubMed ID: 1358893
[TBL] [Abstract][Full Text] [Related]
28. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
29. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
30. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma.
Pich A; Margaria E; Chiusa L; Ponti R; Geuna M
Hum Pathol; 1996 Jul; 27(7):676-82. PubMed ID: 8698311
[TBL] [Abstract][Full Text] [Related]
31. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
[TBL] [Abstract][Full Text] [Related]
32. [Proliferating character of inverted papilloma of the urinary bladder].
Tsujimura A; Takano Y; Oka T; Tei N; Satoh E; Gotoh T; Takaha M; Kurata A; Matsumiya K
Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):618-23. PubMed ID: 9234619
[TBL] [Abstract][Full Text] [Related]
33. Proliferating cell nuclear antigen in normal urothelium and urothelial lesions of the urinary bladder: a quantitative assessment using a true color image analysis system.
Knuechel R; Burgau M; Rueschoff J; Hofstaedter F
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(3):137-44. PubMed ID: 7902171
[TBL] [Abstract][Full Text] [Related]
34. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
[TBL] [Abstract][Full Text] [Related]
36. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
Trerè D; Ceccarelli C; Danova M; Derenzini M
Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
38. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
[TBL] [Abstract][Full Text] [Related]
39. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
40. Nucleolar organizer regions in hepatocellular carcinoma related to the cell cycle, cell proliferation and histologic grade.
Nagao T; Ishida Y; Yamazaki K; Kondo Y
Pathol Res Pract; 1995 Oct; 191(10):967-72. PubMed ID: 8838363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]